Literature DB >> 6749716

Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential.

G Steiner, M Vranic.   

Abstract

This paper reviews and integrates a number of experiments which suggest the existence of a vicious cycle. In this cycle hypertriglyceridemia can lead to insulin resistance even without concomitant obesity or non-insulin dependent diabetes. This insulin resistance may be the basis for the hyperinsulinemia response to a glucose challenge. The hyperinsulinemia can stimulate VLDL-triglyceride production. This increase in production, if it is not accompanied by an equivalent increase in removal, will result in hypertriglyceridemia. The whole cycle would accelerate VLDL-triglyceride turnover and may increase the supply of potentially atherogenic VLDL-remnants.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6749716

Source DB:  PubMed          Journal:  Int J Obes


  13 in total

1.  Triglyceridemia and peroxisome proliferator-activated receptor-alpha expression are not connected in fenofibrate-treated pregnant rats.

Authors:  Ana Soria; Maria del Carmen González; Hubert Vidal; Emilio Herrera; Carlos Bocos
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

2.  Lack of a lipoprotein-induced insulin resistance in hepatoma cells in culture.

Authors:  F Rinninger; B Wolf; H U Haering; W Bachmann
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

3.  The longitudinal effect of the atherogenic index of plasma on type 2 diabetes in middle-aged and older Chinese.

Authors:  Qian Yi; Ziyang Ren; Guannan Bai; Siyu Zhu; Shuting Li; Chunlu Li; Hongjiang Wu; Yimin Zhu; Peige Song
Journal:  Acta Diabetol       Date:  2021-10-14       Impact factor: 4.280

4.  Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

Authors:  A Fontbonne; E Eschwège; F Cambien; J L Richard; P Ducimetière; N Thibult; J M Warnet; J R Claude; G E Rosselin
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

5.  [Persisting hyperlipidemias as risk factors of diabetic macroangiopathy].

Authors:  K H Vogelberg; G Meurers
Journal:  Klin Wochenschr       Date:  1986-06-02

6.  Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

Authors:  E Ferrannini; S M Haffner; B D Mitchell; M P Stern
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

7.  [Relation between body fat distribution, insulin levels and glucose tolerance in obese females].

Authors:  H Hauner; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1988-03-01

8.  Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal study.

Authors:  Yen-Wei Li; Tung-Wei Kao; Pi-Kai Chang; Wei-Liang Chen; Li-Wei Wu
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

9.  Cholesterol-induced hepatic inflammation does not underlie the predisposition to insulin resistance in dyslipidemic female LDL receptor knockout mice.

Authors:  Nanda Gruben; Anouk Funke; Niels J Kloosterhuis; Marijke Schreurs; Fareeba Sheedfar; Rick Havinga; Sander M Houten; Ronit Shiri-Sverdlov; Bart van de Sluis; Jan Albert Kuivenhoven; Debby P Y Koonen; Marten H Hofker
Journal:  J Diabetes Res       Date:  2015-02-28       Impact factor: 4.011

10.  Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects.

Authors:  Flávia De C Cartolano; Gabriela D Dias; Maria C P de Freitas; Antônio M Figueiredo Neto; Nágila R T Damasceno
Journal:  J Diabetes Res       Date:  2017-08-22       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.